OREX Financial Facts

Collaborative agreement: 30.86M
Interest income: 16K
See Full Income Statement

Deferred revenue, less current portion: 32.57M
Total assets: 154.48M
See Full Balance Sheet

Orexigen Therapeutics (OREX) Earnings

  |   Expand Research on OREX
Next EPS Date 3/12/15 *Est. EPS Growth Rate +147.4% *Last Qtr.
Average EPS % Beat Rate +38.3% Revenue Growth Rate +3,505.6% *Last Qtr.
Average % Move 1-Wk after EPS +18.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/10/14 Q314 $0.09-$0.13 +$0.22$30.9M$8.93M N/A Details
8/7/14 Q214 -$0.21-$0.21 $0.00$857K$1M N/A Details
3/12/14 Q413 -$0.21-$0.19 -$0.02$857M$900M N/A Details
11/12/13 Q313 -$0.19-$0.18 -$0.01$857K$800K N/A Details
8/6/13 Q213 -$0.19-$0.19 $0.00N/A$900K N/A Details
3/13/13 Q412 -$0.41-$0.44 +$0.03$857K$910K N/A Details
11/7/12 Q312 -$0.44-$0.30 -$0.14$857K$890K N/A Details
8/7/12 Q212 -$0.25-$0.17 -$0.08$857K$890K N/A Details